Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool.

Kelly-Anne PhillipsYuyan LiaoJonathan BeesleyRobert J MacInnisIan M CollinsRichard BuchsbaumPrue C WeidemanAdrian BickerstaffeStephanie NesciWendy K ChungMelissa C SoutheyJulia A KnightAlice S WhittemoreGillian S DiteDavid GoldgarGraham G GilesGord GlendonJack CuzickAntonis C AntoniouIrene L AndrulisEsther M JohnMary B DalySaundra S BuysJohn L HopperMary Beth Terrynull null

Published in: JNCI cancer spectrum (2019)

For 10-year BC risk, iPrevent had good discriminatory accuracy overall and was well calibrated for women aged younger than 50 years. Calibration may be improved in the future by incorporating IBIS version 8.0b.

Keyphrases

risk assessment
breast cancer risk
polycystic ovary syndrome
type diabetes
skeletal muscle
pregnancy outcomes
low cost
psychometric properties